If you are passionate about health sciences research that makes a difference in people's lives, you're in good hands. We offer award-wining graduate programs led by world-class researchers. You'll have access to top-tier facilities and be working alongside the best and brightest in the field, conducting research that addresses real life problems. Our paradigm-changing approach is collaborative, innovative, and results-driven.
We're tackling diseases like asthma / chronic obstructive pulmonary disease, diabetes, cancer, heart disease, and arthritis. We're developing better ways to deliver drugs and prevent adverse drug reactions. And we're conducting clinical and economic research in pharmaceutical outcomes.
Our reputation as a top research centre attracts some of the brightest and most productive minds in the field. Our faculty has included Canada Research Chairs, Michael Smith Foundation for Health Research Scholars and Senior Scholars, and Distinguished University Scholars.
We are innovators in pharmacy education, research and practice, with the goal of supporting the optimization of drug therapy in the pursuit of improved patient outcomes.
- We support our people, creating a community that enables excellence through collective action.
- We seek novel ideas, putting into practice those with the greatest scope for sustained impact.
- We search for relevant connections, fostering meaningful collaborations that provide mutual benefit.
The Centre for Drug Research and Development (CDRD) is located in our building. CDRD is an independent, non-profit organization with a focus on bridging the gap between academic discoveries in the health sciences and the development of new medicines to treat human disease. The Faculty partners with CDRD to provide unique research and mentoring opportunities for MSc and PhD students.
We are also home to several sophisticated research centres that specialize in the areas of human genome and exome sequencing, and health outcomes research.
Opened in 2012, the Pharmaceutical Sciences building at UBC is a state-of-the-art learning and research facility. The building houses modern, modular labs designed specifically for the type of research intended for the space. Our classroom facilities are fitted with advanced technology to facilitate new modes of learning.
Measuring 246,000 square feet, it's an eye-catching addition to our campus, and has drawn attention and admiration from around the world—including 15 awards of excellence.
As a leading research faculty, we conduct ground-breaking research in the pharmaceutical sciences – all with the goal of addressing the pressing health needs of society and improving lives. Our research activities centre around four areas of focus.
This theme covers our activities in epidemiological analysis, health outcomes and health economics research seeking solutions for the predictive enhancement of intervention strategies for practical and preventive healthcare. The impact of this work is used to shape policy to optimize the allocation of health care resources as well as defining the efficacy of healthcare interventions and strategy.
Molecular & Systems Pharmacology
This highly interdisciplinary theme embodies research directed at the interactions of therapeutic agents with human cells, and covers fundamental questions of the mechanisms of the drug action through to the behaviour of drugs in human systems. These studies are used to inform and optimize the development and delivery of drug intervention regimes for clinical practice and the pharmaceutical industry.
This theme applies our expertise in the chemical biology of the fabrication and handling of nanoscopic materials to drug discovery and delivery. Sensing and screening technologies are also an important focus.
Our research in this theme addresses the issue of scholarship in pharmacy and the pharmaceutical sciences with a view to augment our educational research capacity and enhance the methodologies of teaching practice, student learning and curriculum decision-making.
Graduate Degree Programs
Research Supervisors in Faculty
|Burt, Helen Mary||Nanotechnology, non-sized drug carriers, nanoparticulte drug delivery|
|Cairns, Brian||Neuropharmacology, Oro-Facial Pain, Pain, Electrophysiology, pain mechanisms, headache, temporomandibular disorders, sex-related differences, peripheral analgesics|
|Chang, Thomas||Drug Metabolism, Pharmacology, Nuclear Receptor, Drug-Metabolizing Enzymes, Cytochrome P450, Gene Expression, Gene Regulation|
|Collier, Abby||Drugs in children, Drugs in pregnancy, Developmental pharmacology, Drug metabolism, Pharmacokinetics, Drug metabolism and pharmacokinetics, primarily of the phase II (conjugation) enzymes, focused on pregnancy and pediatrics|
|Conklin, Annalijn||Chronic Diseases in Elderly, Gender Epidemiology, Health Policies, Professional Practices, Obesity, Social Determinants of Dietary and Metabolic Disorders, Community Health / Public Health, healthy ageing, obesity prevention, diabetes management and evaluation, healthcare quality improvement, implementation science, gender and health equity, nutrition-related policy and outcomes|
|Coughtrie, Michael||Drug metabolizing enzymes|
|De Vera, Mary||examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions.|
|Frankel, Adam||Biological and Biochemical Mechanisms, Bioactive Molecules, Organic Molecules and Biomolecules, Proteins, protein biochemistry, arginine methylation, post-translational modifications, drug discovery, yeast, autophagy, chemical biology|
|Giaever, Guri||Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation|
|Grierson, David||Chemistry, disease, biochemistry|
|Hafeli, Urs||Pharmacokinetics, Imaging, Radiotherapy, Immunotherapy, Development of Drug Delivery Systems, Radiopharmaceuticals, Radioimmunotherapy, Magnetic Targeting, Targeted Drug Delivery, Novel polymers, Nanoparticles, Microspheres, Microneedles, Bioconjugates|
|Harrison, Mark||measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered|
|Hedtrich, Sarah||Nanotechnologies, Structural Tissue Engineering / Biomaterials, Inflammatory Respiratory Diseases, Skin, Novel therapies for inflammatory and genetic diseases of human epithelia, Tissue regeneration, Topical drug delivery and Nanomedicine|
|Jarvis-Selinger, Sandra Ann||Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology|
|Kumar, Ujendra||Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs|
|Lalji, Fawziah||Pharmacoepidemiology, Infectious Diseases, Vaccination, Antibiotics and Resistance, Tuberculosis|
|Li, Shyh-dar||drug delivery, pharmaceutics, nanomedicine, biopharmaceutics|
|Loewen, Peter||Arrhythmia, Cardiovascular Diseases, Heart Failure, Stroke, Thrombosis and Embolism, Health Care Technologies, Professional Practices, Pharmacoepidemiology, Hematology, Decision Making, atrial fibrillation, stroke prevention therapy, pharmacy practice, knowledge translation of evidence to patient care, patient education, shared decision-making, clinical prediction rules, prediction of stroke and bleeding in atrial fibrillation patients, patient decision aids, adherence to medication, patient complexiometry, healthcare communication technologies, use of mobile technology for clinical decision-making, hospital pharmacy practice, quality of care, quality drug therapy|
|Lynd, Larry||health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases|
|MacLeod, Kathleen||Cardiovascular complications, diabetes|
|McCormack, James||Knowledge translation and evidence-based practice|
|Nislow, Corey||genomics and develops biotechnology tools to address both fundamental and applied biological questions; Parallel genome-wide chemical genomic screens; High throughput cell-based screens; Next Generation Sequencing|
|Page, Brent||Cell Signaling and Cancer, Drug Discovery, Drug Development, Medicinal Chemistry, Chemical Biology, Cancer, Target Engagement, Cell Signaling|
|Rodrigues, Brian||Diabetes, Cardiomyopathy, Heart Failure, Energy Metabolism, Cardiovascular metabolism, Diabetes, Endothelial cell - cardiomyocyte crosstalk, Vascular Endothelial Growth factors|
Graduate Student Profiles
Alumni on Success
Recent Thesis Submissions
Cholesterol metabolism as a target in castration-resistant prostate cancer (Pharmaceutical Sciences - PHD)
Crosstalk between somatostatin receptor subtypes and cannabinoid receptor 1 in excitotoxicity (Pharmaceutical Sciences - PHD)
Assessment of atrial fibrillation patients' education needs. (Pharmaceutical Sciences - MSC)
Population-level studies of the incremental economic burden of systemic autoimmune rheumatic diseases (Pharmaceutical Sciences - PHD)
Regulation and function of heparanase in the heart (Pharmaceutical Sciences - PHD)
Genetic modifiers of telomere maintenance and their contributions to phenotypic variations in telomere biology disorders (Pharmaceutical Sciences - PHD)
The role of RhoA/ROCK signaling in the development of diabetic cardiomyopathy (Pharmaceutical Sciences - PHD)
The role of Rho kinase 2 in the development of ischemia/reperfusion injury in normal and diabetic hearts (Pharmaceutical Sciences - PHD)
Pharmacologic targeting of the CB2 cannabinoid receptor for application in centrally-mediated chronic pain (Pharmaceutical Sciences - PHD)
Management of gout from the patient perspective (Pharmaceutical Sciences - MSC)
Investigation of the potential application of rhenium in medical imaging (Pharmaceutical Sciences - PHD)
Burst-suppression events and fast, large-amplitude, sharp waves in the cortical EEG during deep isoflurane coma (Pharmaceutical Sciences - MSC)
Study of drug release from an elementary osmotic pump tablet by NMR imaging (Pharmaceutical Sciences - MSC)
Induction of valproic acid metabolism in rat liver microsomes by carbamazepine and carbamazepine-10, 11-epoxide (Pharmaceutical Sciences - PHD)
Crystallinity changes and phase transitions of selected pharmaceutical solids with processing (Pharmaceutical Sciences - PHD)
Indomethacin : Capillary gas chromatographic-electron capture detection analysis and pharmacokinetic studies in the fetal lamb (Pharmaceutical Sciences - MSC)
Synthesis and murine biodistribution of a para and ortho iodinated radiopharmaceutical directed towards the muscarinic receptor (Pharmaceutical Sciences - MSC)
Influence of tamoxifen on hormonally regulated cytochrome P450 enzyme expression in rats (Pharmaceutical Sciences - MSC)
Regulation of protein kinases during postnatal development of rat heart (Pharmaceutical Sciences - PHD)
Role of cGMP-dependent protein kinase in the negative inotropic effects of cGMP-elevating agents in the mammalian ventricle (Pharmaceutical Sciences - PHD)
How do current approaches to communicating ambiguity in risk estimates influence decisions? (Pharmaceutical Sciences - MSC)
Crosstalk and modulation of signaling between somatostatin and growth factor receptors in human breast cancer cell lines (Pharmaceutical Sciences - MSC)